Huadong Medicine Co., Limited’s £166m offer acquisition of Sinclair Pharma plc

Paolo Bossi

Eversheds Sutherland has advised Sinclair Pharma plc (Sinclair) on its proposed cash acquisition by a subsidiary of China’s Huadong Medicine Co (Huadong) which values Sinclair at…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Paolo Bossi

…

This content is for Standard 1 Year members only.
Login Join Now